Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Replicon particle vaccine protects swine against influenza.

Bosworth B, Erdman MM, Stine DL, Harris I, Irwin C, Jens M, Loynachan A, Kamrud K, Harris DL.

Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e99-e103. doi: 10.1016/j.cimid.2010.05.002. Epub 2010 Jun 17.

PMID:
21094422
2.

Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept.

Erdman MM, Kamrud KI, Harris DL, Smith J.

Vaccine. 2010 Jan 8;28(3):594-6. doi: 10.1016/j.vaccine.2009.10.015. Epub 2009 Oct 22.

PMID:
19853679
3.

Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.

Vander Veen RL, Loynachan AT, Mogler MA, Russell BJ, Harris DL, Kamrud KI.

Vaccine. 2012 Mar 2;30(11):1944-50. doi: 10.1016/j.vaccine.2012.01.030. Epub 2012 Jan 23.

PMID:
22269873
5.

A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge.

Tian ZJ, Zhou GH, Zheng BL, Qiu HJ, Ni JQ, Yang HL, Yin XN, Hu SP, Tong GZ.

Vet Immunol Immunopathol. 2006 Jun 15;111(3-4):211-8. Epub 2006 Apr 18.

PMID:
16621018
6.

Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.

Xu J, Yang D, Huang D, Xu J, Liu S, Lin H, Zhu H, Liu B, Lu C.

Arch Virol. 2013 Mar;158(3):629-37. doi: 10.1007/s00705-012-1539-9. Epub 2012 Nov 8.

PMID:
23135159
8.

Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.

Lee JH, Gramer MR, Joo HS.

Can J Vet Res. 2007 Jul;71(3):207-12.

9.

Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.

Xu J, Huang D, Liu S, Lin H, Zhu H, Liu B, Lu C.

Virus Res. 2012 Aug;167(2):188-95. doi: 10.1016/j.virusres.2012.04.014. Epub 2012 May 11.

PMID:
22584406
10.

Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV).

Sipo I, Knauf M, Fechner H, Poller W, Planz O, Kurth R, Norley S.

Vaccine. 2011 Feb 11;29(8):1690-9. doi: 10.1016/j.vaccine.2010.12.037. Epub 2010 Dec 30.

PMID:
21195079
11.

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.

Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.

Arch Virol. 2006 May;151(5):921-31. Epub 2005 Nov 15.

PMID:
16292596
12.

Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.

James CM, Abdad MY, Mansfield JP, Jacobsen HK, Vind AR, Stumbles PA, Bartlett EJ.

Vaccine. 2007 Feb 26;25(10):1856-67. Epub 2006 Nov 3.

PMID:
17240000
13.

Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v.

Kitikoon P, Gauger PC, Anderson TK, Culhane MR, Swenson S, Loving CL, Perez DR, Vincent AL.

Influenza Other Respir Viruses. 2013 Dec;7 Suppl 4:32-41. doi: 10.1111/irv.12189.

14.

Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs.

Xu J, Huang D, Xu J, Liu S, Lin H, Zhu H, Liu B, Chen W, Lu C.

Vet Microbiol. 2013 Feb 22;162(1):259-64. doi: 10.1016/j.vetmic.2012.11.026. Epub 2012 Nov 29.

PMID:
23265244
15.

Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.

Masic A, Lu X, Li J, Mutwiri GK, Babiuk LA, Brown EG, Zhou Y.

Vaccine. 2010 Oct 8;28(43):7098-108. doi: 10.1016/j.vaccine.2010.08.003. Epub 2010 Aug 12.

PMID:
20708697
17.

Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination.

Kitikoon P, Vincent AL, Jones KR, Nilubol D, Yu S, Janke BH, Thacker BJ, Thacker EL.

Vet Microbiol. 2009 Nov 18;139(3-4):235-44. doi: 10.1016/j.vetmic.2009.06.003. Epub 2009 Jun 11.

PMID:
19595522
18.

Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.

Richt JA, Lekcharoensuk P, Lager KM, Vincent AL, Loiacono CM, Janke BH, Wu WH, Yoon KJ, Webby RJ, Solórzano A, García-Sastre A.

J Virol. 2006 Nov;80(22):11009-18. Epub 2006 Aug 30.

19.
20.

Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.

Klingbeil K, Lange E, Blohm U, Teifke JP, Mettenleiter TC, Fuchs W.

Virus Res. 2015 Mar 2;199:20-30. doi: 10.1016/j.virusres.2015.01.009. Epub 2015 Jan 17.

PMID:
25599604

Supplemental Content

Support Center